LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Adoption of New Digital Pathology PACS to Improve Cancer Care for Patients in Sweden

By LabMedica International staff writers
Posted on 11 Nov 2015
Image: Sectra Digital Pathology Solution (Photo courtesy of Sectra).
Image: Sectra Digital Pathology Solution (Photo courtesy of Sectra).
Physicians at the Linköping University Hospital are rolling out a new Internet Technology (IT) solution for the Pathology Department, after completing testing of the system.

The Linköping University Hospital (Linköping, Sweden) serves the Östergötland Swedish healthcare Region and has one the first digital pathology departments in the country. The new system will enable digital review of pathology exams by all 20 pathologists working in the hospital.

The digital pathology Picture Archive and Communications System (PACS) was provided by Sectra (Linköping, Sweden) and will store digital pathology images. The system will enable pathologists and clinicians to improve cancer care by speeding up access to, and sharing of pathology images needed for review, diagnosis, and treatment.

The new Sectra pathology image storage solution will provide pathologists with central storage of pathology images and new tools to support diagnoses and improve review results. Pathologists will have access to images when they need them, for review with all experts, including radiologists and pathologists, involved in the cancer care treatment cycle.

The digital pathology solution uses the same infrastructure as Sectra’s radiology PACS, which is also installed in the Region Östergötland hospital, in the radiology department. This facilitates integrated diagnostics, such as multidisciplinary hospital rounds, and reduces hospital operating, and maintenance costs.

Anna Bodén, Consultant histopathologist at Linköping University Hospital, said, “I read all of my cases digitally and feel very confident about it. Sectra’s solution is fast, easy to use and very stable, which is necessary because we review large volumes and fast answers are decisive for effective cancer care.”

Related Links:

Sectra
Linköping University Hospital


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Capillary Blood Collection Tube
IMPROMINI M3

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more